Agilent Technologies (NYSE:A) today priced a $300 million public offering of senior notes, with proceeds slated to repay its revolving credit facility.
The Santa Clara, Calif.-based company will run the offering under an automatic shelf registration statement, with notes set to mature in September 2026 at an annual interest rate of 3.05%.
Proceeds from the round are slated to repay amounts outstanding under its revolving credit facility and for general corporate purposes, according to a company press release. BNP Paribas Securities Corp, Citigroup Global Markets Inc. and Credit Suisse Securities LLC will act as joint book-running managers for the offer.
Agilent said it expects the offering to close on Sept. 22.
In March, Agilent said it is invested $80 million in next-gen sequencing tech developer Lasergen. With the investment, Agilent will acquire a 48% ownership stake in Lasergen and will join the board, the company said. Agilent will retain the option to acquire the remaining shares until March 2, 2018 for an additional $105 million.
The companies will collaborate to build a next-gen sequencing solutions workflow for clinical applications based on Lasergen’s Lightning Terminator sequencing chemistry, Agilent said.
